While most studies on NAT10 have focused on its role in cancer, where it regulates gene expression to promote tumor progression and resistance to therapy (47–49), lipid metabolism dysregulation has emerged as one of the most prominent metabolic changes associated with cancer (50). The gene discussed is NAT10; the disease is cancer.